Immunovant, Inc. IMVT Switzerland — Total loss before income taxes

Other geography segments

Similar metrics at other companies

GRMNNon Switzerland — Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

$153.35M+42.1%

ZIONZions Bank — Income (loss) before income taxes

$102M+50.0%

TOLSouth — Income (loss) before income taxes

$114.82M-29.5%

GRMNCH — Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

$350.29M+10.9%

CTREPre-Tax Income (Foreign)

$4.53M+108%

ENPHReportable Segment — Income (loss) before income taxes

-$13.86M-130%

Questions, answered.

What is Immunovant, Inc.'s switzerland — total loss before income taxes?

Immunovant, Inc. (IMVT) reported switzerland — total loss before income taxes of -$151.57M in Q1 2026.

How has Immunovant, Inc.'s switzerland — total loss before income taxes changed year-over-year?

Immunovant, Inc.'s switzerland — total loss before income taxes decreased by 53.4% year-over-year, from -$98.78M to -$151.57M.

What is the long-term trend for Immunovant, Inc.'s switzerland — total loss before income taxes?

Over 4 years (2022 to 2026), Immunovant, Inc.'s switzerland — total loss before income taxes has grown at a 52.3% compound annual growth rate (CAGR), from -$112.79M to -$606.29M.

What does switzerland — total loss before income taxes mean?

This metric represents the pre-tax financial loss generated by operations within the Switzerland geographic segment. It reflects the net impact of segment-specific revenues and operating expenses before accounting for income tax provisions. Monitoring this figure helps investors assess the burn rate and operational efficiency of the company's Swiss-based activities.